Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert network.
Axel S MerseburgerGanesh BakshiDong-Yi ChenEdmund ChiongMichel JabbourJae Young JoungAllen Yu-Hung LaiNathan LawrentschukTuan-Anh LeChi Fai NgChoon Ta NgTeng Aik OngJacob See-Tong PangDanny M RabahNarasimhan RagavanKazuhiro SaseHiroyoshi SuzukiMichelle Mui Hian TeoHiroji UemuraHenry H WooPublished in: World journal of urology (2024)
In summary, this article provides insights and guidance to improve management for patients with PCa undergoing ADT.
Keyphrases
- prostate cancer
- cardiovascular disease
- risk assessment
- healthcare
- quality improvement
- palliative care
- radical prostatectomy
- type diabetes
- heavy metals
- clinical practice
- coronary artery disease
- combination therapy
- metabolic syndrome
- chronic pain
- climate change
- cardiovascular risk factors
- affordable care act
- replacement therapy